Traumatic Stupor and Coma <1 Hour w/ MCC DRG Reimbursement

DRG 085 addresses traumatic stupor and coma lasting under one hour with a Major Complication or Comorbidity; it defines the clinical population of short-duration severe neurologic injury requiring acute inpatient care. This matters for inpatient reimbursement because the Major Complication or Comorbidity increases the Diagnosis-Related Group weight and associated Medicare payment for the hospitalization.

DRG 085 Overview

DRG 085 covers inpatient admissions for patients with traumatic stupor and coma lasting less than one hour when a Major Complication or Comorbidity is present. This category captures short-duration severe neurologic insult requiring acute inpatient management, often involving neurosurgical evaluation, intensive monitoring, and supportive care. It matters for Medicare payment because the presence of a Major Complication or Comorbidity increases resource intensity and the relative reimbursement under the Diagnosis-Related Group payment system. Accurate clinical documentation and coding determine assignment to this higher-weighted Diagnosis-Related Group and affect facility payment.

DRG 085 Overview

Acute neuroprotective or resuscitation intervention trials: randomized studies testing emergency interventions (for example, optimized intracranial pressure management protocols, targeted temperature modulation strategies, or rapid hemodynamic optimization bundles) in patients presenting with traumatic stupor or coma lasting under one hour who have major complications or comorbidities. These trials enroll patients in the prehospital or early emergency department period and assess short-term neurologic salvage, survival, and complications; they are relevant because early intervention may alter ICU length of stay, need for intracranial monitoring or surgery, and immediate resource utilization that drive inpatient reimbursement under this DRG.
Comparative effectiveness studies of acute care pathways and surgical timing: observational cohort studies or pragmatic trials comparing care pathways (for example, immediate neurosurgical decompression versus delayed or conservative management, or standardized ICP monitoring protocols versus selective use) in severely injured patients with brief comas and major complications. These studies focus on differences in morbidity, rates of secondary neurologic injury, hospital and ICU LOS, and readmission risk in real-world populations and are important to providers and payers because they inform which approaches yield better outcomes per dollar spent and can influence DRG-related cost drivers and utilization patterns.
Post-acute outcomes and rehabilitation readiness research: longitudinal research following survivors from discharge to 6–12 months to characterize functional recovery trajectories, cognitive outcomes, and rehabilitation needs among patients who experienced traumatic stupor/coma <1 hour with major complications. These studies identify predictors of long-term disability, post-acute care intensity, and durable resource use (home health, skilled nursing, outpatient therapy), providing data that payers and discharge planners use to anticipate downstream costs, optimize case-mix adjustments, and design value-based post-discharge care pathways.

Acute neuroprotective or resuscitation intervention trials: randomized studies testing emergency interventions (for example, optimized intracranial pressure management protocols, targeted temperature modulation strategies, or rapid hemodynamic optimization bundles) in patients presenting with traumatic stupor or coma lasting under one hour who have major complications or comorbidities. These trials enroll patients in the prehospital or early emergency department period and assess short-term neurologic salvage, survival, and complications; they are relevant because early intervention may alter ICU length of stay, need for intracranial monitoring or surgery, and immediate resource utilization that drive inpatient reimbursement under this DRG.
Comparative effectiveness studies of acute care pathways and surgical timing: observational cohort studies or pragmatic trials comparing care pathways (for example, immediate neurosurgical decompression versus delayed or conservative management, or standardized ICP monitoring protocols versus selective use) in severely injured patients with brief comas and major complications. These studies focus on differences in morbidity, rates of secondary neurologic injury, hospital and ICU LOS, and readmission risk in real-world populations and are important to providers and payers because they inform which approaches yield better outcomes per dollar spent and can influence DRG-related cost drivers and utilization patterns.
Post-acute outcomes and rehabilitation readiness research: longitudinal research following survivors from discharge to 6–12 months to characterize functional recovery trajectories, cognitive outcomes, and rehabilitation needs among patients who experienced traumatic stupor/coma <1 hour with major complications. These studies identify predictors of long-term disability, post-acute care intensity, and durable resource use (home health, skilled nursing, outpatient therapy), providing data that payers and discharge planners use to anticipate downstream costs, optimize case-mix adjustments, and design value-based post-discharge care pathways.

OpenPayer

Summary & Overview

Traumatic Stupor and Coma <1 Hour with MCC: Inpatient Reimbursement Overview

DRG 085 Overview

OpenPayer

Summary & Overview

Traumatic Stupor and Coma <1 Hour with MCC: Inpatient Reimbursement Overview

DRG 085 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes